Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NR3C2”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Early research (Phase 1)Study completedNCT01103245
What this trial is testing

Aldosterone and the Metabolic Syndrome

Who this might be right for
Metabolic DiseasesDiabetes MellitusEndocrine System Diseases+1 more
Vanderbilt University Medical Center 69
Testing effectiveness (Phase 2)Study completedNCT02448628
What this trial is testing

Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment

Who this might be right for
Hypertension
Daiichi Sankyo 33
Not applicableUnknownNCT05262660
What this trial is testing

The Long-term Effect of SAAE and Medical Treatment for Primary Aldosteronism

Who this might be right for
Primary Aldosteronism
First Affiliated Hospital of Chengdu Medical College 400
Large-scale testing (Phase 3)Study completedNCT01049347
What this trial is testing

Amitriptyline and Paroxetine Treatment of Major Depression

Who this might be right for
Unipolar Depression
Central Institute of Mental Health, Mannheim 127
Not applicableStudy completedNCT01394627
What this trial is testing

Hypoglycemia and the Mineralocorticoid Receptor

Who this might be right for
Hypoglycemia
Brigham and Women's Hospital 21
Large-scale testing (Phase 3)Study completedNCT01882179
What this trial is testing

Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size

Who this might be right for
ST-elevation Myocardial Infarction
University College, London 61
Post-approval studies (Phase 4)Study completedNCT01837108
What this trial is testing

Eplerenone and Extracellular Adenosine Formation

Who this might be right for
Pharmacodynamics
Radboud University Medical Center 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06655480
What this trial is testing

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

Who this might be right for
HFpEFLVDDMyocardial Fibrosis
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Very early researchActive Not RecruitingNCT07345845
What this trial is testing

MR and Inflammation After Preeclampsia

Who this might be right for
PreeclampsiaPreeclampsia Postpartum
Anna Stanhewicz, PhD 40
Not applicableStudy completedNCT05526157
What this trial is testing

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 50,000
Testing effectiveness (Phase 2)Study completedNCT02345057
What this trial is testing

Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

Who this might be right for
Diabetic Nephropathy
Daiichi Sankyo 365
Not applicableStudy completedNCT04903717
What this trial is testing

Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Yale University 1,210
Not applicableStudy completedNCT01440049
What this trial is testing

Patient's Management Receiving Eplerenone Therapy

Who this might be right for
Left Ventricular Dysfunction Post Myocardial Infarction
Pfizer 160
Testing effectiveness (Phase 2)Study completedNCT04595370
What this trial is testing

Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease

Who this might be right for
Heart FailureChronic Kidney Disease
AstraZeneca 153
Early research (Phase 1)Study completedNCT03450759
What this trial is testing

A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
AstraZeneca 13
Post-approval studies (Phase 4)Study completedNCT03344159
What this trial is testing

Spironolactone Therapy in Chronic Stable Right HF Trial

Who this might be right for
Chronic Right-Sided Heart FailurePulmonary Arterial HypertensionPulmonary Hypertension, Primary, 2+3 more
Ottawa Heart Institute Research Corporation 15
Not applicableLooking for participantsNCT06108427
What this trial is testing

REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study

Who this might be right for
Primary Aldosteronism
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 58
Testing effectiveness (Phase 2)Looking for participantsNCT07029503
What this trial is testing

Swedish Cardiac And Renal Failure Study-1

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionChronic Kidney Disease
Karolinska Institutet 40
Not applicableWithdrawnNCT05806970
What this trial is testing

Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure

Who this might be right for
Heart Failure With Reduced Ejection Fraction
University of California, Los Angeles
Not applicableStudy completedNCT00505336
What this trial is testing

The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure

Who this might be right for
Diastolic Heart Failure
St Vincent's University Hospital, Ireland 43
Load More Results